Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001232946 | SCV001405522 | uncertain significance | Holocarboxylase synthetase deficiency | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change affects codon 18 of the HLCS mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the HLCS protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with HLCS-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001232946 | SCV002083750 | uncertain significance | Holocarboxylase synthetase deficiency | 2020-03-24 | no assertion criteria provided | clinical testing |